FDA grants 510(k) clearance to Fujirebio’s blood-based test for Alzheimer’s
The FDA has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio in vitro diagnostic (IVD) test. The post FDA grants 510(k) clearance to Fujirebio’s blood-based test for Alzheimer’s appeared first on Medical Device Network.
The FDA has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio in vitro diagnostic (IVD) test.
The post FDA grants 510(k) clearance to Fujirebio’s blood-based test for Alzheimer’s appeared first on Medical Device Network.
![[INTERVIEW] 3D Printing at Boston Children’s Hospital: Engineering the Future of Pediatric Surgery](https://3dprintingindustry.com/wp-content/uploads/2025/05/Dr.-David-Hoganson-speaking-at-the-Materialise-3D-Printing-in-Hospitals-Forum-2025.-Photo-via-Materialise3-150x100.jpg?#)
